GSK ANNOUNCES FDA APPROVAL FOR NUCALA (MEPOLIZUMAB) FOR USE IN ADULTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Gsk Announces Fda Approval For Nucala (Mepolizumab) For Use In Adults With Chronic Rhinosinusitis With Nasal Polyps